Back
Ticker avatar

Relmada Therapeutics, Inc. RLMD · Insights

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. ...
Price4.14
Market Cap441.61 M
Float82.64 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscripts
Search in Documents